Colorectal cancer
Conditions
Interventions
Gold Standard:Postoperative imaging examinations and tumor marker monitoring
Index test:The methylation status of Septin9 in plasma
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Participants with pathologically confirmed stage II-III colorectal cancer; 2. Those who have undergone radical surgery (R0 resection); 3. Aged 18-80 years, with no history of other malignant tumors; 4. Complete basic information, including: gender, age, family history, etc.; 5.Able to cooperate with Septin9, CEA, and CT tests; 6.Have signed the informed consent form and can accept long-term follow-up.
Exclusion criteria
Exclusion criteria: 1. Preoperative neoadjuvant chemoradiotherapy administered (to avoid the impact of treatment on methylation status); 2. Complicated with severe hepatic or renal insufficiency, or other chronic diseases affecting survival;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The methylation status of Septin9 in plasma; | — |
Countries
China
Contacts
Public ContactXiaodong Wang
West China Hospital, Sichuan University
Outcome results
None listed